Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2004 1
2005 1
2006 1
2007 3
2008 4
2009 3
2010 1
2012 1
2013 2
2014 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Results by year
Filters applied: . Clear all
Page 1
Molecular pathology of the MEN1 gene.
Agarwal SK, Lee Burns A, Sukhodolets KE, Kennedy PA, Obungu VH, Hickman AB, Mullendore ME, Whitten I, Skarulis MC, Simonds WF, Mateo C, Crabtree JS, Scacheri PC, Ji Y, Novotny EA, Garrett-Beal L, Ward JM, Libutti SK, Richard Alexander H, Cerrato A, Parisi MJ, Santa Anna-A S, Oliver B, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ. Agarwal SK, et al. Among authors: mullendore me. Ann N Y Acad Sci. 2004 Apr;1014:189-98. doi: 10.1196/annals.1294.020. Ann N Y Acad Sci. 2004. PMID: 15153434 Review.
Mitochondrial DNA mutations in pancreatic cancer.
Kassauei K, Habbe N, Mullendore ME, Karikari CA, Maitra A, Feldmann G. Kassauei K, et al. Among authors: mullendore me. Int J Gastrointest Cancer. 2006;37(2-3):57-64. doi: 10.1007/s12029-007-0008-2. Int J Gastrointest Cancer. 2006. PMID: 17827523
ATR inhibition reverses the resistance of homologous recombination deficient MGMTlow/MMRproficient cancer cells to temozolomide.
El Touny LH, Hose C, Connelly J, Harris E, Monks A, Dull AB, Wilsker DF, Hollingshead MG, Gottholm-Ahalt M, Alcoser SY, Mullendore ME, Parchment RE, Doroshow JH, Teicher BA, Rapisarda A. El Touny LH, et al. Among authors: mullendore me. Oncotarget. 2021 Oct 12;12(21):2114-2130. doi: 10.18632/oncotarget.28090. eCollection 2021 Oct 12. Oncotarget. 2021. PMID: 34676045 Free PMC article.
Personalized chemotherapy profiling using cancer cell lines from selectable mice.
Kamiyama H, Rauenzahn S, Shim JS, Karikari CA, Feldmann G, Hua L, Kamiyama M, Schuler FW, Lin MT, Beaty RM, Karanam B, Liang H, Mullendore ME, Mo G, Hidalgo M, Jaffee E, Hruban RH, Jinnah HA, Roden RB, Jimeno A, Liu JO, Maitra A, Eshleman JR. Kamiyama H, et al. Among authors: mullendore me. Clin Cancer Res. 2013 Mar 1;19(5):1139-46. doi: 10.1158/1078-0432.CCR-12-2127. Epub 2013 Jan 22. Clin Cancer Res. 2013. PMID: 23340293 Free PMC article.
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia.
Habbe N, Koorstra JB, Mendell JT, Offerhaus GJ, Ryu JK, Feldmann G, Mullendore ME, Goggins MG, Hong SM, Maitra A. Habbe N, et al. Among authors: mullendore me. Cancer Biol Ther. 2009 Feb;8(4):340-6. doi: 10.4161/cbt.8.4.7338. Epub 2009 Feb 3. Cancer Biol Ther. 2009. PMID: 19106647 Free PMC article.
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT. Chang TC, et al. Among authors: mullendore m. Mol Cell. 2007 Jun 8;26(5):745-52. doi: 10.1016/j.molcel.2007.05.010. Epub 2007 May 31. Mol Cell. 2007. PMID: 17540599 Free PMC article.
21 results